A comparative analysis of tuberculosis treatment outcomes in varied healthcare settings during the COVID-19 pandemic: a case of first-level hospitals in Lusaka district, Zambia

Tuberculosis (TB) remains a major global health challenge, with over 10.6 million cases and 1 million deaths reported in 2022. The COVID-19 pandemic disrupted health service provision, including TB services, especially in low-and-middle-income countries (LMIC). Zambia, a LMIC in sub-Saharan Africa, bears a high burden of TB faced health service interruptions due to COVID-19. This study compared TB treatment outcomes between two first-level hospitals and assessed associated factors. This retrospective cross-sectional study used 2020 data from two purposively selected public first-level hospitals; Chawama and Chilenje in Lusaka District, Zambia. Data were systematically sampled from TB treatment registers, with sample sizes calculated using Cochran’s formula. Analysis involved descriptive statistics, chi-square tests, and multivariable logistic regression at a 95% confidence level using STATA version 14.2. Ethical approval was obtained from the University of Lusaka Ethics Committee and the National Health Research Authority (NHRA).Analysing 548 participants, males (65.2%) and those aged 25–34 (37.1%) were predominant. Chilenje demonstrated a higher proportion of favourable TB treatment outcomes (90.6%) compared to Chawama (83.3%). Patients from Chilenje were twice as likely to have favourable outcomes (OR = 1.933; p = 0.016). When considering factors like age, HIV status, TB type, patient type, and DOT plan, Chawama patients aged 65+ were 71.9% less likely to have favourable outcomes (AOR = 0.281; p = 0.047), whereas at Chilenje, those aged 25–34 were 3.9 times more likely (AOR = 3.869; p = 0.046), and those aged 35–44 were 5.1 times more likely (AOR = 5.111; p = 0.040) compared to those aged 15–24. This study found disparities in TB treatment outcomes between Chawama and Chilenje hospitals during COVID-19, with Chilenje showing better success rates. Differences were linked to facility-level factors and age, with poorer outcomes among the elderly and youth. Recommendations include reallocating resources, strengthening DOTS, targeted support for vulnerable groups, staff training, and adopting pandemic-resilient strategies to improve TB care in Zambia.

Authors

Institutions

Publication Details

Journal
Critical Public Health
Published
2026-02-01
DOI
https://doi.org/10.1080/09581596.2026.2617726
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comparative analysis of tuberculosis treatment outcomes in varied healthcare settings during the COVID-19 pandemic: a case of first-level hospitals in Lusaka district, Zambia

Rodgers Chilyabanyama, Nathan Kamanga, Lilian Lamba, Eustarckio Kazonga
Critical Public Health
Tuberculosis Research and Epidemiology
article

A comparative analysis of tuberculosis treatment outcomes in varied healthcare settings during the COVID-19 pandemic: a case of first-level hospitals in Lusaka district, Zambia

Rodgers Chilyabanyama, Nathan Kamanga, Lilian Lamba, Eustarckio Kazonga
article en

Abstract

Tuberculosis (TB) remains a major global health challenge, with over 10.6 million cases and 1 million deaths reported in 2022. The COVID-19 pandemic disrupted health service provision, including TB services, especially in low-and-middle-income countries (LMIC). Zambia, a LMIC in sub-Saharan Africa, bears a high burden of TB faced health service interruptions due to COVID-19. This study compared TB treatment outcomes between two first-level hospitals and assessed associated factors. This retrospective cross-sectional study used 2020 data from two purposively selected public first-level hospitals; Chawama and Chilenje in Lusaka District, Zambia. Data were systematically sampled from TB treatment registers, with sample sizes calculated using Cochran’s formula. Analysis involved descriptive statistics, chi-square tests, and multivariable logistic regression at a 95% confidence level using STATA version 14.2. Ethical approval was obtained from the University of Lusaka Ethics Committee and the National Health Research Authority (NHRA).Analysing 548 participants, males (65.2%) and those aged 25–34 (37.1%) were predominant. Chilenje demonstrated a higher proportion of favourable TB treatment outcomes (90.6%) compared to Chawama (83.3%). Patients from Chilenje were twice as likely to have favourable outcomes (OR = 1.933; p = 0.016). When considering factors like age, HIV status, TB type, patient type, and DOT plan, Chawama patients aged 65+ were 71.9% less likely to have favourable outcomes (AOR = 0.281; p = 0.047), whereas at Chilenje, those aged 25–34 were 3.9 times more likely (AOR = 3.869; p = 0.046), and those aged 35–44 were 5.1 times more likely (AOR = 5.111; p = 0.040) compared to those aged 15–24. This study found disparities in TB treatment outcomes between Chawama and Chilenje hospitals during COVID-19, with Chilenje showing better success rates. Differences were linked to facility-level factors and age, with poorer outcomes among the elderly and youth. Recommendations include reallocating resources, strengthening DOTS, targeted support for vulnerable groups, staff training, and adopting pandemic-resilient strategies to improve TB care in Zambia.

Critical Public HealthVol. 36(1)
University of Lusaka (ZM), National Institute of Public Administration (ZM), Churches Health Assoication Of Zambia (ZM)
No poverty
Openalex Percentile: Top 68%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.